TY - JOUR
T1 - SOCS1 and regulation of regulatory T cells plasticity
AU - Takahashi, Reiko
AU - Yoshimura, Akihiko
N1 - Publisher Copyright:
© 2014 Reiko Takahashi and Akihiko Yoshimura.
PY - 2014
Y1 - 2014
N2 - Several reports have suggested that natural regulatory T cells (Tregs) lose Forkhead box P3 (Foxp3) expression and suppression activity under certain inflammatory conditions. Treg plasticity has been studied because it may be associated with the pathogenesis of autoimmunity. Some studies showed that a minor uncommitted Foxp3+ T cell population, which lacks hypomethylation at Treg-specific demethylation regions (TSDRs), may convert to effector/helper T cells. Suppressor of cytokine signaling 1 (SOCS1), a negative regulator of cytokine signaling, has been reported to play an important role in Treg cell integrity and function by protecting the cells from excessive inflammatory cytokines. In this review, we discuss Treg plasticity and maintenance of suppression functions in both physiological and pathological settings. In addition, we discuss molecular mechanisms of maintaining Treg plasticity by SOCS1 and other molecules. Such information will be useful for therapy of autoimmune diseases and reinforcement of antitumor immunity.
AB - Several reports have suggested that natural regulatory T cells (Tregs) lose Forkhead box P3 (Foxp3) expression and suppression activity under certain inflammatory conditions. Treg plasticity has been studied because it may be associated with the pathogenesis of autoimmunity. Some studies showed that a minor uncommitted Foxp3+ T cell population, which lacks hypomethylation at Treg-specific demethylation regions (TSDRs), may convert to effector/helper T cells. Suppressor of cytokine signaling 1 (SOCS1), a negative regulator of cytokine signaling, has been reported to play an important role in Treg cell integrity and function by protecting the cells from excessive inflammatory cytokines. In this review, we discuss Treg plasticity and maintenance of suppression functions in both physiological and pathological settings. In addition, we discuss molecular mechanisms of maintaining Treg plasticity by SOCS1 and other molecules. Such information will be useful for therapy of autoimmune diseases and reinforcement of antitumor immunity.
UR - http://www.scopus.com/inward/record.url?scp=84929136427&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929136427&partnerID=8YFLogxK
U2 - 10.1155/2014/943149
DO - 10.1155/2014/943149
M3 - Review article
C2 - 25133199
AN - SCOPUS:84929136427
SN - 2314-8861
VL - 2014
JO - Journal of immunology research
JF - Journal of immunology research
M1 - 943149
ER -